News

D-Bal MAX is a revolutionary new muscle-building supplement that will put you on the fast track to building lean muscle and ...
Tallmadge, Ohio, May 01, 2025 (GLOBE NEWSWIRE) -- Following Over 90 Days of Personal Experience, Here’s What Truly Occurred ...
Comprehensive Healthcare today announced the expansion of its permanent supportive housing program in Sunnyside with the opening of Vista Del Sol-2 (VDS-2), a 20-unit long-term residential housing ...
CONCORD, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) ("Ultrack" or the "Company") is pleased to announce it has entered into a Memorandum of Understanding (MOU) to ...
The Hats On Challenge provides an opportunity to take part in raising awareness of AK. Actinic Keratosis (AK) is a rough, scaly patch on the skin caused by years of sun exposure. If left untreated, AK ...
CHARLESTOWN, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac ...
H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ: Presentation on May 20 at 10:00 a.m. ET. A webcast of the presentations can be accessed here or under “News & Events” in the ...
The live webcasts of the fireside chats will be available on the “Investors & Media” page under the “Events & Presentations” section of the Company’s website at ...
Eascra’s proprietary technology, pioneered by co-founder Dr. Yupeng Chen, can deliver RNA therapeutics to hard-to-reach places like cartilage, kidneys and hard tumors. The long, slender JBNps give ...
To that end, the ACELYRIN Board recommends that stockholders vote “FOR” the merger with Alumis in connection with the upcoming Special Meeting of Stockholders scheduled for May 13, 2025. Every ...
For the first quarter of 2025, Ascendis Pharma reported a net loss of €94.6 million, or €1.58 per share (basic and diluted) compared to a net loss of €131.0 million, or €2.30 per share (basic and ...
Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results ...